Alberta Distributor · Pharmaceutical Grade
Unlock Your Natural Potential
Research-grade peptides sourced, Janoshik-tested, and shipped from Edmonton, Alberta. Your trusted Canadian partner in performance, recovery, and wellness research.
Freedom Peptides is an Alberta-based research peptide distributor based in Edmonton, Alberta, Canada. All products sold on this website are intended strictly for laboratory research and scientific study purposes only.
Freedom Peptides operates in compliance with Canadian law as a distributor of research compounds.
Research-grade peptides sourced, Janoshik-tested, and shipped from Edmonton, Alberta. Your trusted Canadian partner in performance, recovery, and wellness research.
Understanding the molecules that power human biology — and why researchers worldwide are studying them.
Peptides are short chains of amino acids — the same fundamental building blocks that make up proteins. While proteins can contain hundreds or thousands of amino acids, peptides typically consist of just 2 to 50 amino acids linked together.
Think of amino acids as individual LEGO bricks. Proteins are massive LEGO structures. Peptides are the smaller, more targeted pieces — precise enough to fit specific biological locks in your body and trigger very specific responses.
Your body produces thousands of peptides naturally. They act as chemical messengers — regulating everything from tissue repair and immune function to hormone release, metabolism, and even mood.
Insulin — the hormone that regulates blood sugar — is a peptide. Oxytocin — the bonding hormone — is a peptide. GLP-1 — the basis of Ozempic and Wegovy — is a peptide. These molecules are not foreign to your biology. They are your biology.
Unlike traditional synthetic drugs that often work through broad chemical interference, peptides work by mimicking or amplifying signals your body already uses. This makes them highly targeted and of significant scientific interest.
Researchers study peptides for tissue regeneration, metabolic regulation, immune modulation, neuroprotection, and longevity — areas where conventional pharmaceuticals have historically had limited success.
1902 — Secretin becomes the first hormone ever discovered — a peptide. Scientists realize the body uses chemical messengers to coordinate organ function.
1921 — Insulin is isolated by Banting and Best at the University of Toronto. The first therapeutic peptide saves millions of diabetic lives. Canada leads the world.
1953 — Oxytocin becomes the first peptide to be chemically synthesized in a laboratory. Peptide science enters a new era.
1990s-2000s — Rapid expansion of peptide research. BPC-157 isolated from human gastric juice. GHK-Cu identified in human plasma. Thymosin Alpha-1 approved in 35+ countries.
2019 — FDA approves Bremelanotide (PT-141) for female sexual dysfunction — a melanocortin peptide.
2021-2023 — GLP-1 peptide drugs Ozempic and Wegovy achieve mainstream recognition. Retatrutide Phase 2 published in the New England Journal of Medicine showing 24% weight loss.
2025 — SS-31 (Elamipretide) receives FDA accelerated approval for Barth syndrome — the first FDA-approved mitochondria-targeted therapeutic.
Canada has a proud history in peptide science — insulin was discovered here in 1921 at the University of Toronto. Today, Canadian researchers and research enthusiasts have access to a growing body of published evidence on peptide compounds.
Freedom Peptides exists to provide Alberta researchers with pharmaceutical-grade, independently tested peptide compounds backed by real published science — not marketing language.
Every product we carry has peer-reviewed published research behind it. Every select product is Janoshik tested. Every order ships discreetly from Edmonton, Alberta within 48 hours.
Select products independently tested by Janoshik - the UK gold standard in peptide testing. Research-grade quality delivered from Alberta. All prices in Canadian dollars (CAD).
While all products are supplied as SubQ-injectable lyophilized powder, certain peptides have well-documented alternative delivery options researchers may explore.
Two peptides have significant published research supporting topical application. When dissolved into a carrier cream or gel, these peptides can penetrate the dermal layer for localized effects.
GHK-Cu 50mgBPC-157 10mgGHK-Cu - Human clinical trials showed GHK-Cu cream increased skin density and reduced fine lines over 12 weeks. Increases collagen production by 50-70% in fibroblast studies.
BPC-157 - Studied in topical wound-healing models. Best for localized wound, scar, or injury-site application.
Reconstitute your peptide vial with the standard BAC water volume.
Obtain a penetrating carrier base such as liposomal cream or DMSO gel.
Using a sterile syringe, mix peptide solution into cream. Typical ratio 1-2 mL per 30 mL of cream.
Store sealed and refrigerated at 2-8C. Use within 14 days.
Apply a small amount to the target area 1-2 times daily.
Three peptides have substantial published research supporting nasal delivery. The nasal route provides direct access to the brain via the olfactory epithelium, bypassing the blood-brain barrier more efficiently.
Semax 5mgSelank 10mgOxytocin 2mgSemax - Approved in Russia as nasal spray. Crosses blood-brain barrier at 0.093% - nearly 10x more efficiently than IV.
Selank - Approved in Russia as Selank 0.15% nasal drops. Optimal CNS delivery.
Oxytocin - Nasal spray is the most widely studied route for social bonding and stress-reduction effects.
Reconstitute with sterile saline using larger volume. Add 5 mL to 5 mg vial for 1 mg/mL. Each 0.1 mL pump equals 100 mcg.
Obtain a sterile nasal spray bottle (10 mL) from a pharmacy.
Transfer the reconstituted solution into the nasal bottle using a sterile syringe.
Label with peptide name, concentration, and date. Refrigerate at 2-8C. Use within 14 days.
Tilt head slightly forward, insert nozzle, spray once per nostril. Sniff gently after.
Complete dosing guides, reconstitution steps, result timelines, and storage protocols for every product.
We test with Janoshik - a UK-based laboratory and the recognized gold standard for peptide and anabolic testing worldwide.
CoA in progress. Available on request.
CoA in progress. Available on request.
CoA in progress. Available on request.
CoA in progress. Available on request.
All testing is done through Janoshik. Reach out and we will send the relevant CoA before your order ships.
Published research behind each product including FDA approval status, human clinical trial data, and key study citations. We separate animal studies from human trials.
Freedom Peptides is committed to presenting research accurately and without exaggeration. We clearly separate FDA-approved uses from investigational applications. We distinguish animal studies from human trials. We cite real published studies with real PubMed IDs. Where human evidence is limited, we say so. All products are sold for research purposes only.
Evidence-based research protocol combinations using products available at Freedom Peptides.
Science-backed research protocols addressing the unique biological changes of perimenopause and menopause. Because women deserve research designed specifically for them.
Menopause is fundamentally a mitochondrial crisis. Estrogen plays a critical role in mitochondrial function — when estrogen declines, cellular energy production falters. This explains the fatigue, brain fog, metabolic changes, and sleep disruption that accompany perimenopause and menopause. Research into mitochondria-targeted peptides offers a new lens through which to study these changes.
NAD+ levels drop sharply during menopause — up to 50% in some studies — directly impairing sirtuin pathways, DNA repair, and cellular energy. MOTS-C, a mitochondrial-derived peptide, acts as an exercise mimetic that activates AMPK pathways to address the metabolic dysregulation and insulin resistance that accompany estrogen withdrawal. Together they form the foundation of mitochondrial support for menopausal research.
Sleep disruption is one of the most debilitating symptoms of menopause. Epitalon regulates the pineal gland and melatonin production — the exact system disrupted by hormonal changes. With over 35 years of Russian clinical research, Epitalon is one of the most studied longevity peptides specifically for age-related sleep and circadian rhythm disruption.
The hormonal shifts of perimenopause directly affect oxytocin signaling — contributing to increased anxiety, reduced stress resilience, and mood instability. Research-grade oxytocin offers a gentler entry point than PT-141 for studying mood and bonding pathways, with no receptor desensitization, no blood pressure effects, and an excellent tolerability profile making it ideal for women beginning peptide research protocols.
A research-based mitochondrial and hormonal support stack for the perimenopause transition. This five-compound protocol addresses the core biological changes of early hormonal decline — metabolic dysregulation, mitochondrial dysfunction, declining NAD+ levels, mood instability, and disrupted sleep — simultaneously and from multiple biological angles.
Days 1-7: Improved sleep quality and mood stabilization from Epitalon and Oxytocin. Weeks 2-3: Cellular energy improvement from NAD+ and SS-31. Weeks 3-6: Metabolic regulation from MOTS-C. Weeks 6-12: Full mitochondrial optimization and cumulative longevity effects.
A comprehensive cellular regeneration and longevity stack for post-menopause research. This protocol builds on the perimenopause foundation by adding GHK-Cu for the collagen breakdown and skin changes characteristic of post-estrogen decline — supported by multiple human RCTs confirming 50-70% increase in collagen synthesis in women.
Weeks 1-2: NAD+ and SS-31 restore mitochondrial energy baseline. Weeks 3-4: GHK-Cu begins collagen synthesis upregulation. Weeks 5-8: MOTS-C metabolic activation and body composition shifts. Weeks 8-12: Epitalon telomere support and cumulative regenerative effects. Months 3-6: Full post-menopause cellular longevity optimization.
As estrogen declines during menopause, growth hormone pulsatility drops significantly — contributing to loss of lean tissue, increased fat accumulation, reduced skin elasticity, and disrupted sleep architecture. CJC-1295 + Ipamorelin restores natural GH pulses by working with the body's own GH axis rather than replacing it. Combined with GHK-Cu for collagen synthesis and Epitalon for sleep and pineal regulation, this protocol targets the GH-related changes of post-menopause from three complementary angles.
Weeks 1-2: Improved sleep depth and quality from Epitalon and CJC-Ipa pre-bed dosing. Weeks 3-4: Early body composition shifts and improved recovery. Weeks 5-8: GHK-Cu collagen synthesis measurably increases — skin firmness and texture improvements. Weeks 8-12: Full GH axis optimization with lean tissue preservation and sustained fat metabolism improvement.
The KLOW Blend was built for comprehensive regeneration — and its four-compound formula addresses several of the most significant biological changes women experience during perimenopause and post-menopause simultaneously. One daily injection delivering BPC-157, TB-500, GHK-Cu, and KPV in a single vial makes KLOW one of the most convenient and comprehensive research compounds available for women's regenerative health protocols.
Estrogen decline significantly impacts gut barrier integrity and increases intestinal permeability. BPC-157 is researched for gut lining repair, tissue healing, and anti-inflammatory effects — directly addressing the gut health changes that accompany hormonal transition.
Thymosin Beta-4 drives cell migration and systemic tissue repair. Post-menopause connective tissue weakens as collagen production slows. TB-500 supports the cellular repair mechanisms that maintain tissue integrity throughout the body during hormonal decline.
The most powerful collagen-stimulating peptide in the KLOW formula. Multiple human RCTs confirm GHK-Cu increases collagen synthesis by 50-70%. As estrogen withdrawal accelerates skin collagen loss post-menopause, GHK-Cu directly targets this mechanism through a non-hormonal pathway.
The menopausal transition is associated with increased systemic inflammation — sometimes called inflammaging. KPV, derived from alpha-MSH, inhibits NF-kB signaling and reduces pro-inflammatory cytokine production, addressing the inflammatory component of hormonal decline at the cellular level.
Days 3-7: KPV anti-inflammatory effects begin — reduced systemic inflammation. Weeks 2-3: BPC-157 gut repair and tissue healing acceleration. Weeks 3-6: GHK-Cu collagen synthesis measurably increases — skin firmness and elasticity improve. Weeks 6-12: TB-500 systemic connective tissue repair and full regenerative effects of all four compounds working synergistically.
The peptides carried by Freedom Peptides interact with hormonal pathways through multiple biological mechanisms. Understanding these connections helps researchers appreciate why mitochondrial and regenerative peptides are of such significant interest in the context of menopausal hormonal changes.
Oxytocin and estrogen have a bidirectional relationship — estrogen upregulates oxytocin receptors while oxytocin modulates estrogen signaling. As estrogen declines in menopause oxytocin receptor sensitivity changes, contributing to mood instability and reduced stress resilience. Research into oxytocin supplementation during this transition targets this receptor relationship directly.
Epitalon has been specifically researched for its effects on the hypothalamic-pituitary-gonadal axis — the hormonal cascade that controls estrogen and progesterone production. Professor Khavinson's research demonstrated Epitalon's ability to normalize gonadotropin secretion in aging female subjects, suggesting a direct interaction with the hormonal regulatory system disrupted by menopause.
Sex hormones including estrogen and progesterone are produced through steroidogenesis — a mitochondria-dependent process. The mitochondria in steroid-producing cells require optimal membrane integrity to function efficiently. SS-31 targets mitochondrial membranes directly, supporting the cellular machinery responsible for steroid hormone synthesis in tissues where it still occurs post-menopause.
SIRT1 — a sirtuin enzyme activated by NAD+ — plays a direct role in regulating estrogen receptor alpha sensitivity. As NAD+ levels decline during menopause, SIRT1 activity drops, impairing estrogen receptor signaling even in the presence of remaining estrogen. Restoring NAD+ levels supports sirtuin pathway activity and may help maintain receptor sensitivity during the menopausal transition.
Estrogen decline during menopause triggers insulin resistance and metabolic hormone dysregulation — contributing to weight gain, blood sugar instability, and cardiovascular risk. MOTS-C activates AMPK pathways that directly regulate insulin sensitivity and glucose metabolism, addressing the metabolic hormone disruption that accompanies estrogen withdrawal through a mitochondrial rather than hormonal mechanism.
Growth hormone and IGF-1 interact extensively with sex hormone pathways. Estrogen normally supports GH pulsatility — when estrogen declines, GH secretion drops. CJC-1295 + Ipamorelin restores natural GH pulses through the GHRH and ghrelin receptor pathways, supporting IGF-1 levels that interact with estrogen receptors and contribute to bone density, lean tissue, and skin collagen — all areas impacted by estrogen loss.
Estrogen plays a major role in skin collagen maintenance — its decline accelerates collagen loss dramatically in post-menopause. GHK-Cu activates over 4,000 human genes associated with tissue remodeling and has been shown in human RCTs to increase collagen synthesis by 50-70%. While not hormonal in mechanism, GHK-Cu addresses the same collagen breakdown pathway that estrogen normally protects against.
The combination of NAD+ and SS-31 creates a comprehensive mitochondrial support environment that benefits both cellular energy production and steroidogenesis. Research suggests that optimal mitochondrial function in adrenal and ovarian tissues supports whatever residual hormone production remains post-menopause, while also providing the cellular energy substrate needed for all hormonal signaling processes.
📌 Research Use Only: All protocols on this page are for laboratory research and scientific study purposes only. They are not intended to diagnose, treat, cure, or prevent any condition including menopause or perimenopause. Freedom Peptides is an Alberta-based research compound distributor. Always consult a qualified healthcare professional regarding your health.
Everything you need to know before your first order.
Edmonton, Alberta. Janoshik-tested. Transparent from source to door.
Why Freedom Peptides costs more - and why that matters.
We will not pretend our prices match the cheapest options online. They do not - and that is intentional. Select products have been independently tested by Janoshik - a UK-based laboratory widely regarded as the gold standard in peptide and anabolic testing. Their Certificates of Analysis confirm purity percentage and volume.
The peptide market is flooded with underdosed, impure, and mislabelled products sold at bargain prices. We built Freedom Peptides because researchers deserve to know exactly what they are working with.
You are not paying more for a label. You are paying for certainty.
Tested by the UK gold standard in peptide and anabolic testing worldwide.
CoAs confirming purity and volume. Posted publicly and available on request.
Temperature-controlled handling from supplier to your door, every time.
Proudly based in Edmonton, AB. Fast domestic shipping with discreet packaging.
Questions about a product, protocol, or your order? We typically respond within a few hours.
Send your Interac E-Transfer to:
freedom.peptides@gmail.com
Use your order number as the memo/message.
Your order ships within 24-48 business hours of payment confirmation. A tracking number will be emailed to you once your order ships.
A receipt has been sent to your email. Questions? Contact support@freedom-peptides.ca
Last updated: 2026 | Freedom Peptides - Edmonton, Alberta, Canada
Freedom Peptides is an Alberta-based research peptide distributor operating at freedom-peptides.ca, based in Edmonton, Alberta, Canada.
When you place an order or contact us we collect your name, email address, and order details. We do not collect payment card information - all payments are processed via Interac E-Transfer through your own banking institution.
Under Canada's Personal Information Protection and Electronic Documents Act (PIPEDA) you have the right to access, correct, or request deletion of your personal information. Contact us at support@freedom-peptides.ca to exercise these rights.
This website uses session storage only to remember your disclaimer acceptance. We do not use tracking cookies or third-party advertising cookies.
Last updated: 2026 | Freedom Peptides - Edmonton, Alberta, Canada
All products sold by Freedom Peptides are intended strictly for laboratory research and scientific study purposes only. By purchasing you confirm products will be used for research purposes only and not for human consumption.
You must be 18 years of age or older to purchase from Freedom Peptides.
Freedom Peptides operates as a research compound distributor based in Edmonton, Alberta, Canada. All products are distributed in compliance with applicable Canadian federal and Alberta provincial laws.
Nothing on this website constitutes medical advice. Freedom Peptides is not a pharmacy, compounding facility, or healthcare provider. Always consult a qualified healthcare professional.
All sales are final. Exceptions are made only if:
Contact us within 48 hours at support@freedom-peptides.ca with photos. We will arrange a replacement or store credit at our discretion.
US customers are fully responsible for any and all customs duties, import fees, or border decisions. Packages held or seized by US Customs are non-refundable under any circumstances.
These terms are governed by the laws of the Province of Alberta and the laws of Canada. Freedom Peptides is based in Edmonton, Alberta, Canada.
Freedom Peptides - Edmonton, Alberta, Canada
We ship to all provinces and territories across Canada and to the United States.
Orders are processed and shipped within 24-48 business hours of confirmed e-transfer payment to freedom.peptides@gmail.com.
A tracking number will be emailed to you automatically once your order ships. If you have not received tracking within 3 business days of payment confirmation please contact support@freedom-peptides.ca.
All orders ship in discreet plain packaging with no Freedom Peptides branding on the outside. Your privacy is our priority.
By placing a US order you agree that: